Biocon Chair: AI in Clinical Trials Is the Holy Grail

Related Technology stories

• Lack of financial confidence driving consumers to AI assistants

  Finextra • 15 Oct 2026, 12:45

• Anthropic Quarterly Revenue Jumps 45% Before Planned IPO

  PYMNTS • 15 Oct 2026, 10:50

• IPO Failure Rocks the AI Trade

  The Wall Street Journal Markets • 15 Oct 2026, 10:35

• A New Private-Equity Firm Specializes in Giving Companies AI Glow-Ups

  The Wall Street Journal Markets • 15 Oct 2026, 10:00

• CLS completes infrastructure migration with Kyndryl

  Finextra • 15 Oct 2026, 09:33